Page last updated: 2024-08-23

substance p and palonosetron

substance p has been researched along with palonosetron in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alt, J; Cantoreggi, S; Li, Y; Pietra, C; Rojas, C; Sebastiani, S; Slusher, BS; Stathis, M; Thomas, AG; Zhang, J1
Pietra, C; Rojas, C; Slusher, BS; Stathis, M1
Fabi, A; Malaguti, P1

Reviews

1 review(s) available for substance p and palonosetron

ArticleYear
An update on palonosetron hydrochloride for the treatment of radio/chemotherapy-induced nausea and vomiting.
    Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:5

    Topics: Animals; Antiemetics; Antineoplastic Agents; Drug Therapy, Combination; Humans; Isoquinolines; Nausea; Neurokinin-1 Receptor Antagonists; Palonosetron; Practice Guidelines as Topic; Quinuclidines; Radiotherapy; Serotonin 5-HT3 Receptor Antagonists; Substance P; Treatment Outcome; Vomiting

2013

Other Studies

2 other study(ies) available for substance p and palonosetron

ArticleYear
The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits substance P-mediated responses in vitro and in vivo.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:2

    Topics: Action Potentials; Animals; Antiemetics; Antineoplastic Agents; Calcium; Cell Line; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Isoquinolines; Male; Neurokinin-1 Receptor Antagonists; Neurons; Nodose Ganglion; Palonosetron; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Substance P; Vomiting

2010
Inhibition of substance P-mediated responses in NG108-15 cells by netupitant and palonosetron exhibit synergistic effects.
    European journal of pharmacology, 2012, Aug-15, Volume: 689, Issue:1-3

    Topics: Animals; Cell Line, Tumor; Drug Synergism; Isoquinolines; Neurokinin-1 Receptor Antagonists; Palonosetron; Pyridines; Quinuclidines; Receptors, Neurokinin-1; Serotonin 5-HT3 Receptor Antagonists; Substance P

2012